Publication | Closed Access
Mirabegron for treatment of erectile dysfunction concomitant with lower urinary tract symptoms in patients with benign prostatic obstruction: A randomized controlled trial
11
Citations
15
References
2022
Year
Mirabegron improves urinary characteristics and the associated sexual dysfunction in patients with lower urinary tract symptoms/benign prostatic obstruction.
| Year | Citations | |
|---|---|---|
Page 1
Page 1